John J. Aponte
Program for Appropriate Technology in Health
ORCID: 0000-0002-3014-3673Also affiliated with Clinical Insights, Medicines Patent Pool, Seattle University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: “Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9–14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial”.
Anne Schuind, Samuel Adjei, Kalpana Antony, John J. Aponte, Patrick Boakye Yiadom Buabeng +10 more
Kristen M. Connolly, Clarissa Valim, Sélidji Todagbé Agnandji, Amanda Leach, John J. Aponte +27 more
Jason Carnes, William C. Young, Lindsay N. Carpp, Stephen De Rosa, Joseph J. Campo +22 more
Millicent Achola, Jack Hutter, Grace Mboya, Walter Otieno, Jia Jin Kee +16 more